Proceeds from this lot will benefit the Cancer Research Institute (CRI), New York.
The CRI is a 501(c)(3) charitable organization that raises funds for cancer immunology research from individuals, corporations, and foundations. Founded in 1953 by by Helen Coley Nauts and Oliver R. Grace Sr., two individuals who believed that, together, they could end the devastation of cancer. Their legacy is a research center that established an entire field of cancer research—the field of tumor immunology—that is extending and saving the lives of cancer patients today.
Headquartered in New York City, CRI provides direct funding to scientists through fellowships, grants, and awards to fuel the discovery and development of powerful immunotherapies for all types of cancer. The organization aims to accomplish this through support and coordination of research that will yield an understanding of the immune system and its response to cancer, with the ultimate goal of developing immunological methods for the treatment, control, and prevention of the disease.
